Diagnostic Accuracy of Diffusion Weighted Magnetic Resonance Imaging in differentiation between Bbenign and Malignant Soft Tissue Tumors keeping Histopathology as Gold Standard
DOI:
https://doi.org/10.59058/argym503Keywords:
KEY WORDS: Diffusion Weighted Imaging (DWI), Magnetic Resonance Imaging (MRI), soft tissue tumor, Restricted Diffusion.Abstract
Background & Objective: To determine diagnostic accuracy of Diffusion Weighted Magnetic Resonance Imaging in
differentiation between benign and malignant soft tissue tumors keeping histopathology as gold standard.
Methodology: Atotal of 176 patients meeting inclusion criteria underwent MRI, including DWI sequences at b-values of
0, 50, and 1000 s/mm² and ADC values were calculated from corresponding maps. ROI was placed on the solid tumor
component of mass. Post-contrast imaging was also performed. All MRIs were interpreted by blinded, qualified
radiologists to ensure unbiased results. Definitive diagnoses were confirmed through histopathological analysis by
certified pathologists.
Results: 98 (55.69%) were aged 13–40 years and 78 (44.1%) were 41–75 years, with a mean age of 40.62±10.13 years.
There were 94 males (53.5%) and 82 females (46.5%). Tumor sizes ranged from 3.1 cm to 11.5 cm, with a mean size of
6.3 cm. The average ADC value of benign masses (1.50 × 10⁻³ mm²/s) was higher than that of malignant masses (0.83 ×
10⁻³ mm²/s). A cutoff ADC value of 1.1 × 10⁻³ mm²/s provided sensitivity of 85.51%, specificity of 86.84%, PPV of
88.89%, NPV of 82.50%, and diagnostic accuracy of 85.88%. Histopathology showed 97 masses (55.3%) were malignant
and 79 (44.7%) were benign.
Conclusion: Diffusion-weighted MRI (DWI) is a non-invasive, cost-effective imaging tool with 85.5% sensitivity and
86.8% specificity for evaluating soft tissue masses. It can aid early detection of malignant tumors, improving patient
outcomes through timely diagnosis.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- Non-Commercial — You may not use the material for commercial purposes .
- No-Derivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.